| Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial CD Spinner, RL Gottlieb, GJ Criner, JRA López, AM Cattelan, ... Jama 324 (11), 1048-1057, 2020 | 1461 | 2020 |
| Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled … F Ader, M Bouscambert-Duchamp, M Hites, N Peiffer-Smadja, J Poissy, ... The Lancet infectious diseases 22 (2), 209-221, 2022 | 344 | 2022 |
| Utility of hyposmia and hypogeusia for the diagnosis of COVID-19 F Bénézit, P Le Turnier, C Declerck, C Paillé, M Revest, V Dubée, ... The Lancet Infectious Diseases 20 (9), 1014-1015, 2020 | 266 | 2020 |
| Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial FX Lescure, H Honda, RA Fowler, JS Lazar, G Shi, P Wung, N Patel, ... The Lancet Respiratory Medicine 9 (5), 522-532, 2021 | 256 | 2021 |
| Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort J Ghosn, L Piroth, O Epaulard, P Le Turnier, F Mentré, D Bachelet, ... Clinical Microbiology and Infection 27 (7), 1041. e1-1041. e4, 2021 | 133 | 2021 |
| COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021 | 81 | 2021 |
| Hyponatremia is associated with poor outcome in COVID-19 H De Carvalho, T Letellier, M Karakachoff, G Desvaux, H Caillon, ... Journal of Nephrology 34, 991-998, 2021 | 64 | 2021 |
| Lopinavir pharmacokinetics in COVID-19 patients M Gregoire, P Le Turnier, BJ Gaborit, G Veyrac, R Lecomte, D Boutoille, ... Journal of Antimicrobial Chemotherapy 75 (9), 2702-2704, 2020 | 58 | 2020 |
| GS-US-540-5774 Investigators: Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: A randomized clinical trial CD Spinner, RL Gottlieb, GJ Criner, JR Arribas López, AM Cattelan, ... Jama 324 (11), 1048-1057, 2020 | 49 | 2020 |
| Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort S Tubiana, E Varon, C Biron, MC Ploy, B Mourvillier, MK Taha, M Revest, ... Clinical Microbiology and Infection 26 (9), 1192-1200, 2020 | 46 | 2020 |
| Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial V Dubée, PM Roy, B Vielle, E Parot-Schinkel, O Blanchet, A Darsonval, ... Clinical Microbiology and Infection 27 (8), 1124-1130, 2021 | 45 | 2021 |
| Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs P Bastard, SE Vazquez, J Liu, MT Laurie, CY Wang, A Gervais, ... Science immunology 8 (90), eabp8966, 2023 | 41 | 2023 |
| Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID‐19 patients Y Yazdanpanah, French COVID Cohort Investigators and Study Group, ... Journal of Medical Virology 93 (4), 2149-2159, 2021 | 33 | 2021 |
| The value of open-source clinical science in pandemic response: lessons from ISARIC A Abbas, SA Abdukahil, NN Abdulkadir, R Abe, L Abel, L Absil, S Acharya, ... The Lancet infectious diseases 21 (12), 1623-1624, 2021 | 32 | 2021 |
| Ecology, evolution, and epidemiology of zoonotic and vector-borne infectious diseases in French Guiana: Transdisciplinarity does matter to tackle new emerging threats B de Thoisy, O Duron, L Epelboin, L Musset, P Quénel, B Roche, ... Infection, Genetics and Evolution 93, 104916, 2021 | 29 | 2021 |
| High-dose ceftriaxone for bacterial meningitis and optimization of administration scheme based on nomogram M Grégoire, E Dailly, P Le Turnier, D Garot, T Guimard, L Bernard, ... Antimicrobial agents and chemotherapy 63 (9), 10.1128/aac. 00634-19, 2019 | 29 | 2019 |
| Tolerability of high-dose ceftriaxone in CNS infections: a prospective multicentre cohort study P Le Turnier, D Navas, D Garot, T Guimard, L Bernard, P Tattevin, ... Journal of Antimicrobial Chemotherapy 74 (4), 1078-1085, 2019 | 29 | 2019 |
| ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19 M Etienne, N Ettalhaoui, AG Everding, M Evers, I Fabre, M Fabre, ... Scientific data 9 (1), 454, 2022 | 27 | 2022 |
| Epidemiology of human leptospirosis in French Guiana (2007–2014): a retrospective study P Le Turnier, E Mosnier, R Schaub, P Bourhy, A Jolivet, C Cropet, ... The American journal of tropical medicine and hygiene 99 (3), 590, 2018 | 25 | 2018 |
| Update on leptospirosis P Le Turnier, L Epelboin La Revue de medecine interne 40 (5), 306-312, 2018 | 24 | 2018 |
